Titlebook: Breast Cancer; A Guide to Clinical Adnan Aydiner,Abdullah Igci,Atilla Soran Book 2019 Springer Nature Switzerland AG 2019 breast disease.c

foresight

书目名称Breast Cancer影响因子(影响力)




书目名称Breast Cancer影响因子(影响力)学科排名




书目名称Breast Cancer网络公开度




书目名称Breast Cancer网络公开度学科排名




书目名称Breast Cancer被引频次




书目名称Breast Cancer被引频次学科排名




书目名称Breast Cancer年度引用




书目名称Breast Cancer年度引用学科排名




书目名称Breast Cancer读者反馈




书目名称Breast Cancer读者反馈学科排名

象形文字

Eva Below,Wolfram Ebinger,Ulrich Pramannreast as a primary lesion, including liposarcoma, leiomyosarcoma, rhabdomyosarcoma, malignant peripheral nerve sheath tumor, and osteosarcoma. Fibroepithelial tumors are biphasic neoplasms characterized by the proliferation of both epithelial and mesenchymal elements. Fibroadenoma and phyllodes tumors constitute the major entities.

Homocystinuria

镇痛剂

exorbitant

Nuclear Medicine Imaging in Breast Canceraging with PET is a rapidly emerging approach in breast cancer, conventional single-photon nuclear medicine imaging, including bone scintigraphy and sentinel lymph node scintigraphy, still has an important role in the management of breast cancer. This chapter outlines the role of nuclear medicine imaging in patients with breast cancer.

小争吵

indecipherable

In Situ Cancer Treatmentof invasive breast cancer. This chapter focuses on recommendations for workup, primary treatment, risk reduction strategies, and surveillance specific to carcinoma in situ, which represents approximately 20% of all breast cancers diagnosed by mammography.

FRET

被告

Intraoperative Pathological Examination of Breast Lesionsmethod is typically either frozen section (FS) or cytology in addition to gross examination, although some molecular techniques have recently been developed for intraoperative pathological examination (IPE).

Guaff豪情痛饮

Prognostic and Predictive Factorshese assays are based on the identification of prognostic gene signatures by using microarrays. Many groups have attempted to develop genomic tests based on genomic profiling to improve the prediction of clinical outcome compared with standard pathological and clinical markers.